MYC and neoplasm: Unlike most Myc transgenic models with strong transcriptional enhancers, such as MMTV, that can drive tumors on their own, our model requires additional oncogenic hits to drive tumorigenesis, allowing for the evolution of cellular heterogeneity, including different levels of post-translational MYC stabilization across tumor subtypes.